{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:43:22Z","timestamp":1792763002805,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"CORE","doi-asserted-by":"publisher","award":["Grant P30"],"award-info":[{"award-number":["Grant P30"]}],"id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Number TL1R001858"],"award-info":[{"award-number":["Number TL1R001858"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.actbio.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T21:19:09Z","timestamp":1520543949000},"page":"261-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease"],"prefix":"10.1016","volume":"71","author":[{"given":"Michelle L.","family":"Ratay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Balmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J.","family":"Bassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2018.03.002_b0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry Eye Disease","volume":"130","author":"William Stevenson","year":"2012","journal-title":"Arch. Ophthamol."},{"issue":"Suppl 2","key":"10.1016\/j.actbio.2018.03.002_b0010","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/S0039-6257(00)00203-4","article-title":"The ocular surface and tear film and their dysfunction in dry eye disease","volume":"45","author":"Rolando","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.actbio.2018.03.002_b0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0039-6257(00)00202-2","article-title":"Dry eye disease: the scale of the problem","volume":"45","author":"Brewitt","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.actbio.2018.03.002_b0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S5555","article-title":"Etiology, prevalence, and treatment of dry eye disease","volume":"3","author":"Gayton","year":"2009","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.actbio.2018.03.002_b0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea."},{"key":"10.1016\/j.actbio.2018.03.002_b0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2003.09.003","article-title":"The role of the lacrimal functional unit in the pathophysiology of dry eye","volume":"78","author":"Stern","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0035","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression","volume":"182","author":"Chauhan","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0040","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","article-title":"Desiccating stress induces T cell-mediated Sjogren \u2019 s Syndrome-like lacrimal keratoconjunctivitis","volume":"176","author":"Niederkorn","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/mi.2013.20","article-title":"Chronic dry eye disease is principally mediated by effector memory Th17 cells","volume":"7","author":"Chen","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.actbio.2018.03.002_b0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1189\/jlb.0606383","article-title":"An eye\u2019s view of T regulatory cells","volume":"81","author":"Stein-Streilein","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.actbio.2018.03.002_b0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/archophthalmol.2009.125","article-title":"Amelioration of murine dry eye disease by topical antagonist to chemokine receptor 2","volume":"127","author":"Goyal","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.actbio.2018.03.002_b0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00232","article-title":"Peripherally induced Tregs-role in immune homeostasis and autoimmunity","volume":"4","author":"Yadav","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00046","article-title":"Regulatory T cells as immunotherapy","volume":"5","author":"Singer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0085","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2012.01.013","article-title":"Controlled release formulations of IL-2, TGF-\u03b21 and rapamycin for the induction of regulatory T cells","volume":"159","author":"Jhunjhunwala","year":"2012","journal-title":"J. Control. Release."},{"key":"10.1016\/j.actbio.2018.03.002_b0090","doi-asserted-by":"crossref","first-page":"17527","DOI":"10.1038\/s41598-017-17869-y","article-title":"TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model","volume":"7","author":"Ratay","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2018.03.002_b0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jconrel.2017.07.006","article-title":"In vivo induction of regulatory T cells promotes allergen tolerance and suppresses allergic contact dermatitis","volume":"261","author":"Balmert","year":"2017","journal-title":"J. Control. Release."},{"key":"10.1016\/j.actbio.2018.03.002_b0100","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Tao","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2018.03.002_b0105","first-page":"47","article-title":"Histone deacetylase inhibitors (HDACIS): Multitargeted anticancer agents","volume":"7","author":"Ververis","year":"2013","journal-title":"Biol. Targets Ther."},{"key":"10.1016\/j.actbio.2018.03.002_b0110","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1182\/blood-2011-10-292003","article-title":"Histone\/protein deacetylases and T-cell immune responses","volume":"119","author":"Akimova","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2018.03.002_b0115","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nm1652","article-title":"Deacetylase inhibition promotes the generation and function of regulatory T cells","volume":"13","author":"Chen","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2018.03.002_b0120","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1073\/pnas.0700298104","article-title":"FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression","volume":"104","author":"Li","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2018.03.002_b0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cellimm.2009.03.004","article-title":"Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors","volume":"257","author":"Lucas","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0130","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.exphem.2012.06.008","article-title":"Impact of HDAC inhibitors on dendritic cell functions","volume":"40","author":"Frikeche","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.actbio.2018.03.002_b0135","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.4049\/jimmunol.0804388","article-title":"Cutting edge: negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3 1","volume":"182","author":"Sun","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.transproceed.2008.01.039","article-title":"Effects of histone deacetylase inhibitor SAHA on effector and FOXP3+Regulatory T cells in Rhesus macaques","volume":"40","author":"Johnson","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.actbio.2018.03.002_b0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2017.05.007","article-title":"Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease","volume":"258","author":"Ratay","year":"2017","journal-title":"J. Control. Release."},{"key":"10.1016\/j.actbio.2018.03.002_b0150","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1167\/iovs.14-16307","article-title":"Topical TSG-6 administration protects the ocular surface in two mouse models of inflammation-related dry eye","volume":"56","author":"Lee","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2018.03.002_b0155","first-page":"632","article-title":"A mouse model of keratoconjunctivitis sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2018.03.002_b0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.ICL.0000161705.19602.C9","article-title":"Effect of experimental dry eye on tear sodium concentration in the mouse","volume":"31","author":"Stewart","year":"2005","journal-title":"Eye Contact Lens."},{"key":"10.1016\/j.actbio.2018.03.002_b0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.actbio.2018.03.002_b0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation","volume":"9","author":"Tang","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1359-6446(04)03309-4","article-title":"Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?","volume":"10","author":"Blanchard","year":"2005","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.actbio.2018.03.002_b0180","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clim.2010.04.018","article-title":"Histone\/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs","volume":"136","author":"Akimova","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0185","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0190","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archopht.126.8.1046","article-title":"Evaluation of topical cyclosporine for the treatment of dry eye disease","volume":"126","author":"Perry","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.actbio.2018.03.002_b0195","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.eye.6701895","article-title":"Corticosteroid-induced glaucoma: a review of the literature","volume":"20","author":"Kersey","year":"2006","journal-title":"Eye"},{"key":"10.1016\/j.actbio.2018.03.002_b0200","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/cncr.29177","article-title":"Histone deacetylase inhibitors in cancer: What have we learned?","volume":"121","author":"Whittle","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.actbio.2018.03.002_b0205","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2147\/IJN.S64100","article-title":"Safety evaluation of poly(lactic-co-glycolic acid)\/poly(lactic-acid) microspheres through intravitreal injection in rabbits","volume":"9","author":"Rong","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2018.03.002_b0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.eye.6700566","article-title":"Tears in health and disease","volume":"17","author":"Tiffany","year":"2003","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.actbio.2018.03.002_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajpath.2016.02.004","article-title":"Interferon-\u03b3\u2013induced unfolded protein response in conjunctival goblet cells as a cause of mucin deficiency in Sj\u00f6gren Syndrome","volume":"186","author":"Coursey","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actbio.2018.03.002_b0220","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1167\/iovs.13-13577","article-title":"Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model","volume":"55","author":"Zhang","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2018.03.002_b0225","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: Proceedings of the ocean group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.actbio.2018.03.002_b0230","first-page":"467","article-title":"Conjunctival epithelial and goblet cell function in chronic inflammation and ocular allergic inflammation","volume":"14","author":"Gangaraju","year":"2014","journal-title":"Curr. Opin. Clin. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0235","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.gastro.2009.10.037","article-title":"Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice","volume":"138","author":"De Zoeten","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.actbio.2018.03.002_b0240","first-page":"257","article-title":"A mouse dry eye model induced by topical administration of benzalkonium chloride","volume":"17","author":"Lin","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.actbio.2018.03.002_b0245","first-page":"1","article-title":"Vital dyes in ophthalmology: a chemical perspective","author":"Badaro","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0250","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1167\/iovs.08-1730","article-title":"Mechanisms of murine lacrimal gland repair after experimentally induced inflammation","volume":"49","author":"Zoukhri","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2018.03.002_b0255","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02854841","article-title":"A new look at dry eye disease and its treatment","volume":"17","author":"Nelson","year":"2000","journal-title":"Adv. Ther."},{"key":"10.1016\/j.actbio.2018.03.002_b0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preteyeres.2014.10.001","article-title":"Clinical staining of the ocular surface: Mechanisms and interpretations","volume":"44","author":"Bron","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0265","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1167\/iovs.08-2417","article-title":"Characterization of effector T cells in dry eye disease","volume":"50","author":"El Annan","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2018.03.002_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078508","article-title":"Chemokine receptors CCR6 and CXCR3 are necessary for CD4+ T cell mediated ocular surface disease in experimental dry eye disease","volume":"8","author":"Coursey","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2018.03.002_b0275","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry eye as a mucosal autoimmune disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0280","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.actbio.2018.03.002_b0285","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1167\/iovs.11-9417","article-title":"Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease","volume":"53","author":"Na","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.actbio.2018.03.002_b0290","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2013.08.013","article-title":"T helper cytokines in dry eye disease","volume":"117","author":"Pflugfelder","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4049\/jimmunol.128.1.337","article-title":"Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation","volume":"128","author":"Palacios","year":"1982","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0300","first-page":"190","article-title":"Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor","volume":"21","author":"Gantner","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.actbio.2018.03.002_b0305","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1038\/ncomms9266","article-title":"GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation","volume":"6","author":"Xiao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2018.03.002_b0310","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4049\/jimmunol.182.1.148","article-title":"Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation","volume":"182","author":"Chauhan","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2018.03.002_b0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/02713680903453494","article-title":"The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model","volume":"35","author":"Seo","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0320","first-page":"1","article-title":"Mesenchymal stem\/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye","author":"Lee","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2018.03.002_b0325","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2005.21.139","article-title":"Preservation of Tear Film Integrity and Inhibition of Corneal Injury by Dexamethasone in a Rabbity Model of Lacrimal Gland Inflammation -Induced Dry Eye","volume":"21","author":"Nagelhout","year":"2005","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.actbio.2018.03.002_b0330","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exer.2013.11.011","article-title":"Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye","volume":"118","author":"Zhang","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2018.03.002_b0335","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","article-title":"Lifitegrast, a novel integrin antagonist for treatment of dry eye disease","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.actbio.2018.03.002_b0340","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1038\/s41598-017-09379-8","article-title":"Long term glaucoma drug delivery using a topically retained gel\/microsphere eye drop","volume":"7","author":"Fedorchak","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2018.03.002_b0345","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.2174\/1381612821666150316120024","article-title":"Mouse models of primary Sjogren \u2019 s Syndrome","volume":"21","author":"Park","year":"2015","journal-title":"Curr. Pharm."},{"key":"10.1016\/j.actbio.2018.03.002_b0350","first-page":"1","article-title":"Current concepts: mouse models of Sj\u00f6gren\u2019s syndrome","volume":"2011","author":"Lavoie","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.actbio.2018.03.002_b0355","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/nrd3031","article-title":"Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells","volume":"8","author":"Wang","year":"2009","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118301223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706118301223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:06:33Z","timestamp":1761671193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706118301223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":71,"alternative-id":["S1742706118301223"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2018.03.002","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}